FATE logo Fate Therapeutics : FATE

FATE

Stock Data

$1.10

Change up

$0.02 (1.85%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Fate Therapeutics Inc is a pioneering biopharmaceutical firm based in San Diego, California, focusing on the creation of innovative cellular immunotherapies for cancer and immune disorders. The company is at the forefront of developing treatments using natural killer (NK) and T-cells, targeting conditions like multiple myeloma, lymphoma, autoimmune disorders, hematologic malignancies, and solid tumors. Through a strategic partnership with Ono Pharmaceutical Co. Ltd., Fate Therapeutics is advancing the development of off-the-shelf, iPSC-derived CAR T-cell therapies, aiming to revolutionize cancer treatment.

All Fate Therapeutics Articles

20 Articles

1 2

Our $500K AI Portfolio

See us invest in our favorite AI stock ideas for free

Our Investment Portfolio